Using the TipRanks Stock Screener Tool, we identified three companies that have low Price-to-Earnings (P/E) ratios and hold a “Stron......

Ecora Royalties PLC ( ($GB:ECOR) ) has issued an announcement. Ecora Royalties PLC will hold a live interactive presentation on 14 April 2026 to di......

A class action lawsuit was filed against Corcept Therapeutics ($CORT) on February 20, 2026. Plaintiffs -shareholders- in the federal securities cla......

Berenberg Bank analyst maintained a Buy rating on Ecora Royalties PLC yesterday and set a price target of p180.00. In addition to Berenberg Bank, E......

Cora Gold ( ($GB:CORA) ) has provided an update. Cora Gold Limited, the AIM-quoted West African gold developer, has closed a previously announced f......

There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Ottobock SE & Co. KGaA (OBCKF) and Corcept Therapeutics (COR......

In a report released on March 26, Ben Davis from RBC Capital maintained a Buy rating on Ecora Royalties PLC, with a price target of p190.00. The co......

Cora Gold ( ($GB:CORA) ) has provided an update. Cora Gold has completed a £15.7m equity fundraise via a subscription and retail offering at 6 penc......

Corcept Therapeutics (CORT) told investors approval was on track through December 2025. Then the company disclosed that the FDA had issued a Comple......

The latest update is out from Corcept Therapeutics ( ($CORT) ). On March 25, 2026, Corcept Therapeutics announced U.S. FDA approval of Lifyorli (re......